AzTrials
AzTrials

Creative DramaNCT07073599

Increasing Midwifery Students' Awareness of Breast and Gynecological Cancers Using Creative Drama Method

A study testing Creative Drama Education in people with Creative Drama, run by Ataturk University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama. Read more about this study

Who is it for?
Ages 18 to 35 years, women only
Conditions the study is for
Creative Drama
What is being tested?
Creative Drama Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2025to 1 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being between the ages of 18-35,
  • Not having any health problems,
  • Agreeing to participate in the study,

Who cannot join

  • Students who are under 18 or over 35 years old.
  • Students who do not voluntarily agree to participate in the study will not be included in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zülbiye DEMİR BARBAK, 1 contact

+905435164229

zulbiye.demir@atauni.edu.tr

Sultan Esra SAYAR, Lecturer contact

+905302935474

esra.tedik@atauni.edu.tr

Turkey (Türkiye)1 site
  • Ataturk University Faculty of Health Sciences

    Erzurum, Center, 25000

    Zülbiye DEMİR BARBAK, LECTURER, 05435164229, zulbiye.demir@atauni.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Breast and Gynecological Cancer Education Using Creative Drama Method on Midwifery Students' Awareness: A Randomized Controlled Trial

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.

Read the detailed description

The study will involve 50 volunteer midwifery students between the ages of 18 and 35 studying at the Faculty of Health Sciences. Students will be randomized and assigned to experimental and control groups. Awareness levels of breast and gynecological cancers in both groups will be determined. Students in the intervention group will be administered a creative drama exercise. Data will be collected using a Personal Information Form, the Breast Cancer Awareness Scale, and the Gynecological Cancer Awareness Scale.

Conditions
Creative Drama
Being tested
Creative Drama Education
Keywords
Creative drama, Breast and gynecological cancers, Midwifery students, Awareness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creative Drama EducationOther

    This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers.

    Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers.

    The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used:

    Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.

Study groups in NCT07073599
Study groupRoleWhat they receive
Control GroupNo interventionThe control group will receive routine training and no action will be taken.
Experimental GroupExperimentalStudents in the intervention group will be given a creative drama session. This will evaluate the impact of creative drama training on breast and gynecological cancer awareness.
Receives: Other: Creative Drama Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Personel Information Form

    The researcher will prepare a form based on literature information and will question the students' sociodemographic characteristics.

    Measured: Baseline

  2. Gynecological Cancers Awareness Scale

    To assess women's knowledge levels about gynecological cancers, Dal and Ertem developed the Gynecological Cancer Awareness Scale (GCAAS) in 2017. The scale consists of 41 questions and four subscales. 10. The scale can only be applied to women. The Cronbach's alpha value of the scale is 0.944. Questions 20-41 of the scale determine "Awareness of Routine Check-up and Perception of Serious Illness in Gynecological Cancers," and the Cronbach's alpha value of this subscale is 0.979. Questions three through 11 of the scale determine "Awareness of Gynecological Cancer Risks," and the Cronbach's alpha value of this subscale is 0.843. Questions 14-19 of the scale determine "Awareness of Prevention of Gynecological Cancers," and the Cronbach's alpha value is 0.778. The first and second questions of the scale, as well as the 12th and 13th questions, determine "Early Diagnosis and Information Awareness in Gynecological Cancers," and the Cronbach's Alpha value is 0.708.

    Measured: Baseline and up to 4 weeks

  3. Breast Cancer Awareness Scale

    The scale was developed by Rakkapao et al. (2016) for the early detection and prevention of breast cancer. It is easy to use and was designed as a self-report tool that allows researchers and practitioners to better understand women's breast cancer awareness levels. The original scale consists of five factors and 35 items. Adapted to our language by Altuntuğ et al. in 2021, the scale obtained a five-factor structure with 29 items. The subdimensions of the scale were found to have good internal consistency. The Cronbach's alpha internal consistency coefficients for the subdimensions of the scale were 0.87 for Knowledge of Risk Factors, 0.88 for Knowledge of Signs and Symptoms, 0.81 for Breast Cancer Prevention Attitudes, 0.78 for Barriers to Breast Screening, and 0.61 for Health Behavior Related to Breast Cancer Awareness.

    Measured: Baseline and up to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2025
  2. Study start1 Aug 2025 (estimated)
  3. Primary completion1 Nov 2025 (estimated)
  4. Study completion1 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07073599
Sponsor's protocol ID
Creative drama in midwifery
Status last verified
Jul 2025
First submitted
10 Jul 2025
Last updated
18 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Erci B, Karabulut N. Appraising the self-assessed support needs of Turkish women with breast cancer. Eur J Cancer Care (Engl). 2007 Mar;16(2):137-43. doi: 10.1111/j.1365-2354.2006.00721.x.

    PubMed 17371422
  • Sayar SE, Barbak ZD. Effect of gynecological and breast cancer education using a creative drama method on midwifery students' awareness: a randomized controlled trial. BMC Nurs. 2026 Feb 13;25(1):261. doi: 10.1186/s12912-026-04407-3.

    PubMed 41688990

Questions about this trial

What is this clinical trial studying?

A study testing Creative Drama Education in people with Creative Drama, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zülbiye DEMİR BARBAK, 1 (+905435164229, zulbiye.demir@atauni.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Personel Information Form (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07073599, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in